Pharmaceutical composition for intranasal administration, compri

Details Pharmaceutical composition for intranasal administration, compri Pharmaceutical composition for intranasal administration, compri

1988-07-25

1991-04-23

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

424 43, 424 45, 424 46, 424489, 424499, 514937, 514938, 514944, 514964, 514965, A61K 3702, A61K 906, A61K 912, A61K 914

Patent

active

050100564

ABSTRACT:
A pharmaceutical composition for intranasal administration comprising GHRH, a cholinergic agonist and in case a bile salt, suitable for the treatment of growth disorders and for use in the diagnosis of GH hypophyseal functionality.

REFERENCES:
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4663318 (1987-05-01), Davis
patent: 4818531 (1989-04-01), Anderson et al.
patent: 4880778 (1989-11-01), Bowers et al.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for intranasal administration, compri does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for intranasal administration, compri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for intranasal administration, compri will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1621427